AaronKopmanMD

PubMed

• 2 citations
  Sugammadex Is Not a Silver Bullet: Caveats Regarding Unmonitored Reversal.
  Michael M Todd, Aaron F Kopman> ;Anesthesiology. 2023 Jul 1
• My first decade in anaesthesia: A memoir.
  Aaron F Kopman> ;Anaesthesia, Critical Care & Pain Medicine. 2023 Apr 1
• 3 citations
  Measuring Success of Patient Safety Initiatives: The 2023 American Society of Anesthesiologists Practice Guidelines for Monitoring and Antagonism of Neuromuscular Bloc...
  Sorin J Brull, Aaron Kopman> ;Anesthesiology. 2023 Jan 1
• 2 citations
  Clarifications on Technologies to Optimize Care of Severe COVID-19 Patients.
  Sorin J. Brull, Aaron F. Kopman> ;Anesthesia and Analgesia. 2020 Oct 1
• 1 citations
  Not another requiem for succinylcholine. Comment on Br J Anaesth 2020 10.1016/j.bja.2020.06.025
  Aaron F. Kopman, Sorin J. Brull> ;British Journal of Anaesthesia. 2020 Aug 1
• 18 citations
  Anesthesiologists' Overconfidence in Their Perceived Knowledge of Neuromuscular Monitoring and Its Relevance to All Aspects of Medical Practice: An International Survey.
  Mohamed Naguib, Sorin J. Brull, Jennifer M. Hunter, Aaron F. Kopman, Béla Fülesdi, Ken B. Johnson, Hal R. Arkes> ;Anesthesia and Analgesia. 2019 Jun 1
• 5 citations
  Neuromuscular Monitoring: Keep It Simple!
  Mohamed Naguib, Aaron F. Kopman> ;Anesthesia and Analgesia. 2019 Jun 1
• Neostigmine-induced weakness after sugammadex - a reply.
  Kopman, A.,Naguib, M.> ;Anaesthesia. 2019 Jan 19
• 2 citations
  Neuromuscular monitoring and reversal: responses to the POPULAR study.
  Hans D de Boer, Sorin J. Brull, Mohamed Naguib, Glenn S. Murphy, Aaron F. Kopman> ;The Lancet. Respiratory Medicine. 2019 Feb 1
• Neostigmine-induced weakness: what are the facts?
  Naguib, M.,Kopman, A. F.> ;Anaesthesia. 2018 Aug 23
• 4 citations
  Neostigmine as an antagonist of residual block: best practices do not guarantee predictable results.
  G.S. Murphy, A.F. Kopman> ;British Journal of Anaesthesia. 2018 Aug 1
• Anesthesiologists' Overconfidence in Their Perceived Knowledge of Neuromuscular Monitoring and Its Relevance to All Aspects of Medical Practice: An International Survey.
  Naguib, M.,Brull, S. J.,Hunter, J. M.,Kopman, A. F.,Fülesdi, B.,Johnson, K. B.,Arkes, H. R.> ;Anesth. Analg.. 2018 Aug 24
• 165 citations
  Consensus Statement on Perioperative Use of Neuromuscular Monitoring.
  Mohamed Naguib, Sorin J. Brull, Aaron F. Kopman, Jennifer M. Hunter, Béla Fülesdi, Hal R. Arkes, Arthur S. Elstein, Michael M. Todd, Ken B. Johnson> ;Anesthesia and Analgesia. 2017 Nov 1
• 153 citations
  Current Status of Neuromuscular Reversal and Monitoring: Challenges and Opportunities.
  Sorin J. Brull, Aaron F. Kopman> ;Anesthesiology. 2017 Jan 1
• 23 citations
  "To Reverse or Not To Reverse?": The Answer Is Clear!
  Glenn S. Murphy, Aaron F. Kopman> ;Anesthesiology. 2016 Oct 1
• 1 citations
  Neuromuscular Blockers and Electroconvulsive Therapy: How Much Is Enough?
  Aaron F. Kopman, Mohamed Naguib> ;Anesthesia and Analgesia. 2016 Oct 1
• 42 citations
  Is deep neuromuscular block beneficial in laparoscopic surgery? No, probably not.
  Aaron F. Kopman, Mohamed Naguib> ;Acta Anaesthesiologica Scandinavica. 2016 Jul 1
• 39 citations
  The Myth of Rescue Reversal in "Can't Intubate, Can't Ventilate" Scenarios
  Mohamed Naguib, Lara Brewer, Cristen LaPierre, Aaron F. Kopman, Ken B. Johnson> ;Anesthesia and Analgesia. 2016 Jul 1
• In Response.
  Aaron F Kopman, Mohamed Naguib> ;Anesthesia and Analgesia. 2016 Jan 1
• 6 citations
  Neostigmine: You Can’t Have It Both Ways
  Aaron F. Kopman, Mohamed Naguib> ;Anesthesiology. 2015 Jul 1
• 65 citations
  Laparoscopic Surgery and Muscle Relaxants: Is Deep Block Helpful?
  Aaron F. Kopman, Mohamed Naguib> ;Anesthesia and Analgesia. 2015 Jan 1
• 23 citations
  Current recommendations for monitoring depth of neuromuscular blockade.
  Cynthia A. Lien, Aaron F. Kopman> ;Current Opinion in Anaesthesiology. 2014 Dec 1
• Recovery times after sugammadex: is the data flawed?
  Kopman AF> ;Acta Anaesthesiol Scand. 2014-04-01
• Postanesthesia evaluation of neuromuscular function.
  Aaron F. Kopman> ;Anesthesiology. 2013 Sep 1
• Low-dose Sugammadex Reversal: There Is No Such Thing as a Free Lunch.
  Kopman, A. F.,Brull, S. J.> ;Anesthesiology. 2013 Jul
• Join now to see all

Journal Articles

• The TOF-Watch(R) monitor: Failure to calculate the TOF ratio in the absence of baseline calibration in anaesthetized dogs  
  Martin-Flores M, Gleed RD, Basher K, Scarlett J, Campoy L, Kopman AF, Br J Anaesth, 1/1/2012
• Neuromuscular dose-response studies. Determining sample size  
  Kopman AF, Lien CA, Naguib M, Br J Anaesth, 1/1/2011
• A survey of current neuromuscular practice in the United States and Europe  
  Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ, Anesth Analg, 1/1/2010
• Determining the potency of neuromuscular blockers: Are traditional methods flawed?  
  Kopman AF, Lien CA, Naguib M, Br J Anaesth, 1/1/2010
• Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis  
  Naguib M, Kopman AF, Ensor JE, British Journal of Anaesthesia, 1/1/2007
• Antagonism of profound cisatracurium and rocuronium block: The role of objective assessment of neuromuscular function  
  Kopman AF, Kopman DJ, Ng J, Zank L, J Clin Anesth, 1/1/2005
• The effect of nitrous oxide on the dose-response relationship of rocuronium  
  Kopman AF, Chin W, Moe J, Malik R, Anesthesia & Analgesia, 1/1/2005
• Dose-response relationship of rocuronium. A comparison of electromyographic vs. acceleromyographic-derived values  
  Kopman AF. Chin WA, Acta Anaesthesiologica Scandinavica, 1/1/2005
• Acceleromyography versus electromyography: An ipsilateral comparison of the indirectly evoked neuromuscular response to train-of-four stimulation  
  Kopman AF, Chin W, Cyriac J, Acta Anaesthesiologica Scandinavica, 1/1/2005
• Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of two. Should quantitative assessment of neuromuscular function be mandatory?  
  Kopman AF, Zank LM, Ng J, Neuman GG, Anesth Analg, 1/1/2004
• Model to describe the degree of twitch potentiation during neuromuscular monitoring  
  Eleveld DJ, Kopman AF; Proost JH, Wierda JM, Br J Anaesth, 1/1/2004
• Acceleromyography as a guide to anesthetic management. A case report  
  Kopman AF, Sinha N, J Clin. Anesth, 1/1/2003
• Low-dose rocuronium and tracheal intubation  
  Naguib M, Kopman AF, Middle East Journal of Anesthesiology, 1/1/2003
• The “intubating dose of succinylcholine.” The effect of decreasing doses on recovery time  
  Kopman AF, at al, Anesthesiology, 1/1/2003
• The relationship between acceleromyographic train-of-four fade and single twitch depression  
  Kopman AF, Klewicka MM, Neuman GG, Anesthesiology, 1/1/2002
• The staircase phenomenon. Implications for monitoring of neuromuscular transmission  
  Kopman AF, Kumar S, Klewicka MM, Neuman GG, Anesthesiology, 1/1/2001
• Reexamined: The recommended “intubating dose” for nondepolarizing blockers of rapid-onset  
  Kopman AF, Klewicka MM, Neuman GG, Anesth Analg, 1/1/2001
• Precurarization and priming: A theoretical analysis of safety and timing  
  Kopman AF, Kahn N, Neuman GG, Anesth Analg, 1/1/2001
• An alternate method of estimating the dose-response relationships for neuromuscular blocking drugs  
  Kopman AF, Klewicka MM, Neuman GG, Anesth Analg, 1/1/2000
• Dose-response and onset/offset characteristics of rapacuronium  
  Kopman AF, Klewicka MM, Neuman GG, Flores F, Ghori K, Anesthesiology, 1/1/2000
• Pharmacokinetic studies of neuromuscular blocking agents: Good clinical research practice (GCRP)  
  Viby-Mogensen J, Ostergaard D, Fisher D, Hunter J, Kampmann JP, Kopman AF, Proost H, Rasmussen SN, Skovgaard LT, Varin F, Wright PMC, Acta Anaesthesiol Scand, 1/1/2000
• Molar potency is predictive of the speed of onset of neuromuscular block for agents of intermediate-, short-, and ultra-short duration  
  Kopman, AF, Klewicka MM, Kopman DJ, Neuman GG, Anesthesiology, 1/1/1999
• Molar Potency is not predictive of the speed of onset of atracurium  
  Kopman, AF, Klewicka MM, Neuman GG, Anesth Analg, 1/1/1999
• Correlation of the train-of-four fade ratio with clinical signs and symptoms of residual curarization in awake volunteers  
  Kopman AF, Yee PS, Neuman GG, Anesthesiology, 1/1/1997
• Re-establishment of paralysis using mivacurium following apparent full clinical recovery from mivacurium-induced neuromuscular block  
  Kopman AF, Justo MD, Mallhi MU, Neuman GG, Anaesthesia, 1/1/1996
• Join now to see all

Books/Book Chapters

• Current Anesthesiology Reports 
  Chapter: Management Principles to Reduce the Risk of residual neuromuscular blockade 
  Page 130 - 138Brull SJ, Kopman AF, Naguib M2013
• Yao & Artusio’s Anesthesiology: Problem-Oriented Patient Management 
  Chapter: Prolonged post-operative apnea and residual neuromuscular weakness 
  Page 1184 - 1199Kopman D, Kopman AFEditors: Fun-Sun F. Yao..Lippincott Williams & Wilkens, Philadelphia, PAEdition 7th ,2012
• ASA Refresher Courses in Anesthesiology 
  Chapter: Monitoring neuromuscular function. Facts and fallacies 
  Page 72 - 79Kopman AFLippincott Williams & Wilkins, Philadelphia, PA2011
• Monitoring in Anesthesia and Perioperative Care. David Reich Editor 
  Chapter: Neuromuscular monitoring 
  Page 261 - 280Kopman AFCambridge University Press, NY2011
• Controversial Drugs in Clinical Practice. Audio-Digest Anesthesiology 
  Chapter: Succinylcholine: A marvel whose time has passed? 
  Kopman AF2008
• Residual neuromuscular block has consequences 
  Page 363 - 364Kopman AF2008
• Seminars in Anesthesia, Perioperative Medicine and Pain 
  Chapter: Neuromuscular blocking agents: New insights and old controversies 
  Page 75 - 85Kopman AF2002
• Current Opinion in Anesthesiology 
  Chapter: Measurement and monitoring of neuromuscular blockade 
  Page 415 - 420Kopman AF2002
• Geriatric Anesthesiology 
  Chapter: Clinical use of relaxants in the geriatric patient 
  Kopman AFEditors: McKleskey CH.Williams & Wilkins, Baltimore1996
• Muscle Relaxants: Physiologic and Pharmacologic Aspects 
  Chapter: Reversal of mivacurium: neostigmine, edrophonium, or spontaneous recovery - Which makes more sense? 
  Kopman AFEditors: Fukushima K, Ochiai R.Springer-Verlag, Tokyo1995
• Clinical pharmacology and practical applications of neuromuscular blockers and antagonists 
  Chapter: Clinical pharmacology and practical applications of neuromuscular blockers and antagonists 
  Lein CA, Savarese JJ, Kopman AFEditors: Bowdle TA.Churchill Livingstone, NY1994
• Anesthesiology Clinics of North America 
  Chapter: What is really new about the new relaxants? 
  Page 729 - 778Lien CA, Belmont MR, Kopman AF, Savarese JJEditors: Ornstein E.W. B. Saunders Co., Philadelphia1993
• Refresher Courses in Anesthesiology 
  Chapter: New and currently available muscle relaxants 
  Page 255 - 282Lien CA, Belmont MR, Kopman AF, Savarese JJJ. P. Lippincott1993
• Progress in Anesthesiology 
  Chapter: Reversal of neuromuscular blockade 
  Kopman AFDannemiller Memorial Educational Foundation, San Antonio, TX1992
• Anesthesiology Review 
  Chapter: Recovery and reversal of neuromuscular blocking agents: Ambulatory surgery considerations 
  Page 21 - 27Kopman AF1990
• Problems in Anesthesia: Neuromuscular Relaxants 
  Chapter: Antagonism of profound neuromuscular blockade 
  Kopman AFEditors: Stephen M.Rupp, Lippincott, Philadelphia1989
• Current Opinion in Anaesthesiology 
  Chapter: Neuromuscular blocking drugs: Recovery and reversal 
  Kopman, AF1988
• Problems in Anesthesia: A Case Study Approach 
  Chapter: Differential diagnosis of hypercarbia 
  Page 29 - 38Kopman AFEditors: Mark Ravin.Little Brown & Co., N.Y.1981
• Join now to see all

Abstracts/Posters

• Optimal sample size for determining potency of neuromuscular blocking agents
  Kopman AF, Lien CA, Br J Anaesth, 1/1/2009
• A dose-response study of rocuronium. Do acceleromyographic and electromyographic monitors produce the same results?
  Kopman AF. Chin WA., Anesthesiology, 1/1/2004
• The effect of an elastic preload on the acceleromyographic recorded response of the adductor pollicis to indirect stimulation
  Chin WA, Kopman AF., Anesthesiology, 1/1/2004
• Acceleromyography versus electromyography: An ipsilateral comparison of the indirectly evoked neuromuscular response to train-of-four stimulation
  Kopman AF, Chin W, Cyriac J, Anesthesiology, 1/1/2004
• Dose-response relationships of 430A under propofol, nitrous oxide, opioid anesthesia
  Belmont MR, Lien CA, Tjan J, Patel SS, Kopman AF, 2003 ASA Annual Meeting, 1/1/2003
• Reexamined: The recommended “intubating dose” for nondepolarizing blockers of rapid-onset
  Kopman AF, Klewicka MM, Neuman GG, 2001 ASA Meeting, New Orleans, 1/1/2001
• Dose-response and onset/offset characteristics of rapacuronium
  Kopman AF, Klewicka MM, Neuman GG, Flores F, Ghori K, Anesthesiology, 1/1/2000
• Ability of the bispectral index (BIS) to predict verbal responsiveness in patients undergoing intravenous sedation
  Mathews D, Greenwald S, Kumar S, Kopman AF, Neuman G, Anesthesiology, 1/1/2000
• Patterns and costs of pre-operative Testing: Preop clinic vs. outside testing
  Mathews D, Klewicka M, Kopman AF, Neuman GG, Anesthesiology, 1/1/2000
• Molar potency is not predictive of the speed of onset of atracurium. Abstract presented. Annual Meeting American Soc. Anesthesiology
  Kopman AF, Klewicka MM, Neuman GG, Anesthesiology, 10/1/1999
• Onset of neuromuscular block following subparalyzing doses of cisatracurium, vecuronium, rocuronium, and succinylcholine
  Kopman AF, Klewicka MM, Kopman DJ, Neuman GG, Anesthesiology, 1/1/1998
• Post-operative residual curarization: Pancuronium versus mivacurium
  Kopman AF, American Society of Anesthesiologist Annual Meeting, 10/1/1996
• Post-operative residual curarization: Pancuronium versus mivacurium
  Kopman AF, Ng J, Zank L, Neuman GG, Yee P, Anesthesiology, 1/1/1996
• Comparison oh the recovery profile of mivacurium and vecuronium in 1,163 patients
  Apfelbaum JL, Grasela TH, Kopman AF, McLeskey CH, Nabulsi A, Roizen MF, Viby Mogensen J, Thirsted RA, Walawander CA, Anesth Analg, 1/1/1995
• Respiratory function in the PACU: Results of a phase IV study of mivacurium and vecuronium
  Roizen MF, Walawander CA, Grasela TH, Viby Mogensen J, Apfelbaum JL, Kopman AF, McLeskey CH, Nabulsi A, Anesth Analg, 1/1/1995
• The influence of electrode placement of EMG amplitude and subjective pain
  Fernandes L, Brull S, Printsev Y, Silverman D, Kopman AF, Anesthesiology, 1/1/1995
• Train-of-four count as an indicator of the extent of neuromuscular block: A reappraisal
  Kopman AF, Mallhi M, Justo M, Rodricks P, Anesthesiology, 1/1/1994
• Postoperative nausea/vomiting and the effect of anticholinesterase agents
  Grasela TH, McLeskey CH, Walawander CA, Kopman AF, Nabulsi A, Roizen MF, Viby-Mogensen J, Thited RA, Apfelbaum JL, Anesthesiology, 1/1/1994
• Frequency and importance of mivacurium-induced flushing
  McLeskey CH, Walawander CA, Nabulsi A, Roizen MF, Viby-Mogensen J, Thited RA, Apfelbaum JL, Grasela TH, Kopman AF, Anesthesiology, 1/1/1994
• Efficacy and safety of divided dose administration of mivacurium for rapid tracheal intubation
  Ali HH, Brull S, Witkowski T, Kopman AF, Silverman D, Anesthesiology, 1/1/1993
• Incidence of post-dural puncture headache in outpatient arthroscopy using a 27 gauge Whitacre needle
  Smyth JP, Spenser JT, Kopman AF, Anesthesiology, 1/1/1993
• Join now to see all

Lectures

• Post-operative residual neuromuscular block and its clinical consequences 
  6/1/2013
• Undetected post-operative residual neuromuscular block. It’s more common than you think 
  4/1/2013
• Post-operative residual neuromuscular block: Incidence and consequences 
  1/1/2013
• Anesthesia Patient Safety Foundation panel: Residual muscle relaxant induced weakness in the postoperative period. Is it a patient safety issue? 
  12/1/2012
• Refresher Course Lecture: Monitoring perioperative neuromuscular function. Facts, fallacies and controversies 
  10/1/2011
• Managing intra-operative neuromuscular block: Facts, fallacies, and unmet needs 
  11/1/2010
• Refresher Course Lecture: Monitoring perioperative neuromuscular function. Facts and fallacies 
  10/1/2010
• Neuromuscular block for short procedures & new developments in reversal strategies 
  12/1/2009
• The ED95, current controversies. Implications for the clinician 
  7/1/2009
• Undetected post-operative neuromuscular block has clinical implications 
  12/1/2008
• Neuromuscular blocking agents; Current controversies and a peek into the future 
  10/1/2008
• Resident Research Forum 
  10/1/2008
• Unmet clinical needs in anesthesiology 
  10/1/2008
• Neuromuscular block. Hot topics 2007 
  12/1/2007
• Is it time to retire succinylcholine? 
  12/1/2007
• Recovery from nondepolarizing blockers: Current problems and future solutions 
  10/1/2007
• Novel neuromuscular blocking and reversal agents 
  10/1/2007
• Muscle Relaxants 2007: Current issues 
  6/1/2007
• Post-operative residual curarization: Is it a real problem? Is it preventable? 
  3/1/2007
• Miniworkshop: Should objective monitoring of neuromuscular block be mandatory? Will sugammadex change current standards? 
  12/1/2006
• What Is the Future of Reversal Agents for Antagonism of Non-Depolarizing Neuromuscular Blockade? 
  10/1/2006
• Scientific Papers Session 
  10/1/2005
• Acceleromyography 
  6/1/2005
• Miniworkshop: Is objective monitoring of neuromuscular block mandatory? 
  12/1/2004
• Moderator, scientific papers session 
  10/1/2004
• Join now to see all

Other

• Postanesthesia evaluation of neuromuscular function 
  Kopman AF
  1/1/2013
• Is post-operative residual neuromuscular block associated with adverse clinical outcomes? What is the evidence? 
  Kopman AF, Brull SJ
  1/1/2013
• Low dose sugammadex. There is no free lunch 
  Kopman AF, Brull SJ
  1/1/2013
• Clinical experience: A potential hazard 
  Kopman AF
  1/1/2012
• Rescue reversal: An addendum 
  Kopman AF, Kurata J
  1/1/2012
• "Can't-Intubate, Can't-Ventilate." Is Rescue Reversal a Pipe-Dream? 
  Kopman AF, Kurata J
  1/1/2012
• Neuromuscular Block: Not only Czech beer deserves a taste: In response 
  Kopman AF
  1/1/2011
• A survey of practice of neuromuscular block in the United States and Europe: A response 
  Naguib M, Kopman AF, Lien CA, Hunter JM, Brull SJ
  1/1/2011
• Sugammadex dose requirements at post-tetanic counts of one to two. Cost implications 
  Kopman AF
  1/1/2010
• Determining the potency of neuromuscular blockers. A response 
  Kopman AF, Lien CA, Naguib M
  1/1/2010
• Managing Neuromuscular Block: Where are the guidelines? 
  Kopman AF
  1/1/2010
• Neostigmine vs. Sugammadex: Which, when and how much? 
  Kopman AF
  1/1/2010
• Reversal of nondepolarizing neuromuscular blockers: Current practice 
  Kopman AF, Eikerman M
  1/1/2009
• How low can you go? Lowest effective muscle relaxant dose for tracheal intubation 
  Kopman AF
  1/1/2009
• Neuromuscular monitoring: Old issues – new controversies 
  Kopman AF
  1/1/2009
• Residual neuromuscular block and adverse respiratory events 
  Kopman AF
  1/1/2008
• Neuromuscular monitoring and postoperative residual curarisation: A response 
  Naguib M, Kopman AF, Ensore JE
  1/1/2007
• Sugammadex-rocuronium dosing 
  Kopman AF
  1/1/2007
• Can conventional peripheral nerve stimulators induce direct muscle depolarization? 
  Kopman AF
  1/1/2006
• Rocuronium vs. succinylcholine for rapid tracheal intubation 
  Kopman AF
  1/1/2006
• An analysis of the TOF-Watch algorithm for modifying the displayed train-of-four fade ratio 
  Kopman AF, Kopman DJ
  1/1/2006
• Sugammadex: A revolutionary approach to neuromuscular antagonism 
  Kopman AF
  1/1/2006
• The Datex-Ohmeda M-NMT module. A potentially confusing user interface 
  Kopman AF
  1/1/2006
• Normalization of the acceleromyographic train-of-four fade ratio 
  Kopman AF
  1/1/2005
• Monitoring neuromuscular blockade often overlooked 
  Kopman AF
  1/1/2005
• Join now to see all